Youssef, N.; Noureldein, M.; Njeim, R.; Ghadieh, H.E.; Harb, F.; Azar, S.T.; Fares, N.; Eid, A.A.
Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases. Biomedicines 2021, 9, 1360.
https://doi.org/10.3390/biomedicines9101360
AMA Style
Youssef N, Noureldein M, Njeim R, Ghadieh HE, Harb F, Azar ST, Fares N, Eid AA.
Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases. Biomedicines. 2021; 9(10):1360.
https://doi.org/10.3390/biomedicines9101360
Chicago/Turabian Style
Youssef, Natalie, Mohamed Noureldein, Rachel Njeim, Hilda E. Ghadieh, Frederic Harb, Sami T. Azar, Nassim Fares, and Assaad A. Eid.
2021. "Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases" Biomedicines 9, no. 10: 1360.
https://doi.org/10.3390/biomedicines9101360
APA Style
Youssef, N., Noureldein, M., Njeim, R., Ghadieh, H. E., Harb, F., Azar, S. T., Fares, N., & Eid, A. A.
(2021). Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases. Biomedicines, 9(10), 1360.
https://doi.org/10.3390/biomedicines9101360